import streamlit as st
import google.generativeai as genai

# --- ğŸ¥ å©¦ç™Œè‡¨åºŠå°èˆªèˆ‡å¯¦è­‰åœ–æ›¸é¤¨ (2026 æ——è‰¦æœ€çµ‚ç‰ˆ) ---
st.set_page_config(page_title="å©¦ç™Œè‡¨åºŠè©¦é©—å°èˆªç³»çµ±", layout="wide")

# åˆå§‹åŒ– session_state
if 'selected_trial' not in st.session_state:
    st.session_state.selected_trial = "ğŸ“š RUBY"

st.markdown("""
    <style>
    @import url('https://fonts.googleapis.com/css2?family=Noto+Sans+TC:wght@400;700;900&family=Roboto:wght@400;700;900&display=swap');
    
    /* === UI é«˜å°æ¯”åº¦èˆ‡ç·Šç·»åŒ– === */
    html, body, [class*="css"] {
        font-family: 'Noto Sans TC', 'Roboto', sans-serif;
        background-color: #F4F7F9; color: #1A1A1A;
        font-size: 19px !important; line-height: 1.1;
    }

    .main-title {
        font-size: 32px !important; font-weight: 900; color: #004D40;
        padding: 5px 0; border-bottom: 3px solid #4DB6AC; margin-bottom: 5px;
    }

    /* éšæ®µæ–¹å¡Šï¼šæ·±è‰²æ¼¸å±¤èƒŒæ™¯ */
    .big-stage-card {
        border-radius: 10px; padding: 0px; 
        box-shadow: 0 4px 15px rgba(0,0,0,0.1);
        border: 2px solid transparent; background: white; 
        margin-bottom: 4px; overflow: hidden; height: auto !important;
    }
    .big-stage-header {
        font-size: 18px !important; font-weight: 900; color: white !important;
        padding: 8px; text-align: center; text-shadow: 1px 1px 2px rgba(0,0,0,0.3);
    }

    .card-p-tx { border-color: #1B5E20; }
    .header-p-tx { background: linear-gradient(135deg, #2E7D32, #1B5E20); } /* æ·±ç¶  */
    .card-p-mt { border-color: #0D47A1; }
    .header-p-mt { background: linear-gradient(135deg, #1565C0, #0D47A1); } /* æ·±è— */
    .card-r-tx { border-color: #E65100; }
    .header-r-tx { background: linear-gradient(135deg, #EF6C00, #BF360C); } /* æ·±æ©˜ç´… */
    .card-r-mt { border-color: #4A148C; }
    .header-r-mt { background: linear-gradient(135deg, #6A1B9A, #4A148C); } /* æ·±ç´« */

    .sub-block {
        margin: 2px 4px; padding: 4px; border-radius: 6px; 
        background: #F8F9FA; border-left: 5px solid #455A64;
    }
    .sub-block-title {
        font-size: 14px; font-weight: 900; color: #263238;
        margin-bottom: 1px; border-bottom: 1.1px solid #CFD8DC; padding-bottom: 1px;
    }

    /* æŒ‰éˆ•æ¨£å¼ï¼šæ·±é»‘è‰²åŠ ç²— (#1A1A1A) */
    .stPopover button { 
        font-weight: 900 !important; font-size: 11px !important; 
        border-radius: 4px !important; margin-top: 1px !important;
        padding: 1px 6px !important; width: 100% !important; 
        text-align: left !important; color: #1A1A1A !important; 
        border: 1px solid rgba(0,0,0,0.15) !important;
        box-shadow: 0 1px 3px rgba(0,0,0,0.1) !important;
    }
    
    .stPopover button[aria-label*="ğŸ“š"] { background: #ECEFF1 !important; border-left: 5px solid #455A64 !important; }
    .stPopover button[aria-label*="ğŸ“"] { background: #E1F5FE !important; border-left: 5px solid #0288D1 !important; } 

    .detail-section { background: white; border-radius: 18px; padding: 25px; border: 1px solid #CFD8DC; box-shadow: 0 10px 40px rgba(0,0,0,0.05); }
    .hr-big-val { font-family: 'Roboto', sans-serif; font-size: 36px !important; font-weight: 900; color: #D84315; }
    </style>
    """, unsafe_allow_html=True)

# --- 1. æŒ‡å¼•èˆ‡è·¯å¾‘æ•¸æ“šåº« ---
guidelines_nested = {
    "Endometrial": [
        {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [
            {"title": "dMMR / MSI-H", "content": "é¦–é¸ï¼šå«é‰‘åŒ–ç™‚ + PD-1 (RUBY/GY018/AtTEnd)ã€‚"},
            {"title": "pMMR / NSMP", "content": "è¦– ER/Grade æ±ºç­–ï¼›ä¸€ç·šåŠ ç¶­æŒ (DUO-E)ã€‚äºŒç·šé¸æ¨™é¶å…ç–« (KN775)ã€‚"},
            {"title": "POLE mutation", "content": "é å¾Œæ¥µä½³ï¼Œæ—©æœŸå¯é™éšæ²»ç™‚ï¼›æ™šæœŸä»å±¬ Rare åˆ†å‹ã€‚"},
            {"title": "p53 mutation", "content": "é å¾Œæœ€å·®ã€‚å»ºè­°åŒ–æ”¾ç™‚ç©æ¥µä»‹å…¥ã€‚Serous å‹éœ€é©— HER2ã€‚"}]},
        {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [{"title": "IO Maintenance", "content": "ä¸€ç·š IO å¾Œæ¥çºŒç¶­æŒè‡³ PD (DUO-E/RUBY)ã€‚"}]},
        {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (Recurr Tx)", "css": "r-tx", "subs": [{"title": "Recurrent EC", "content": "æ¨™æº–äºŒç·šï¼šPembro + Lenva (MSS) æˆ–å–®è—¥ IO (GARNET)ã€‚"}]},
        {"id": "R-MT", "header": "å¾©å¾Œç¶­æŒ (PR-Maint)", "css": "r-mt", "subs": [{"title": "Continuous Therapy", "content": "ç¶­æŒæœ‰æ•ˆæ²»ç™‚ç›´åˆ°é€²å±•ã€‚"}]}
    ],
    "Ovarian": [
        {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [
            {"title": "HGSC / Endometrioid", "content": "Surgery + Carbo/Pacli Â± Bevã€‚è€ƒæ…® IDS + HIPEC (van Driel)ã€‚"},
            {"title": "Mucinous (MOC) é‘‘å®š", "content": "åˆ¤å®šï¼šCK7+/SATB2- (åŸç™¼)ã€‚Expansile (é å¾Œä½³) vs Infiltrative (æ˜“è½‰ç§»)ã€‚"}]},
        {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [
            {"title": "BRCA mutation", "content": "Olaparib å–®è—¥ç¶­æŒ 2å¹´ (SOLO-1)ã€‚"}, 
            {"title": "HRD positive / BRCA wt", "content": "PAOLA-1 (Ola+Bev) æˆ– PRIMA (Nira)ã€‚"},
            {"title": "HRD negative", "content": "Niraparib ç¶­æŒ (PRIMA ITT) æˆ– Bevã€‚"}]},
        {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (Recurr Tx)", "css": "r-tx", "subs": [
            {"title": "PSOC (Sensitive Recur)", "content": "PFI > 6mã€‚è©•ä¼°äºŒæ¬¡æ‰‹è¡“ (DESKTOP III) æˆ–å«é‰‘é›™è—¥ã€‚"},
            {"title": "PROC (Resistant Recur)", "content": "PFI < 6mã€‚å–®è—¥åŒ–ç™‚ Â± Bev æˆ–æ¨™é¶ ADC (MIRASOL)ã€‚"}]},
        {"id": "R-MT", "header": "å¾©å¾Œç¶­æŒ (PR-Maint)", "css": "r-mt", "subs": [{"title": "Platinum Sensitive Maint", "content": "æ•‘æ´ç·©è§£å¾Œé¸ PARPi ç¶­æŒ (NOVA/ARIEL3/SOLO2)ã€‚"}]}
    ],
    "Cervical": [
        {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [
            {"title": "Locally Advanced (CCRT)", "content": "åŒæ­¥åŒ–æ”¾ç™‚ Â± IO (A18) æˆ– èª˜å°åŒ–ç™‚ (INTERLACE/CALLA)ã€‚"},
            {"title": "Early Stage (Surgery)", "content": "æ ¹æ²»è¡“ (LACC) æˆ–å–®ç´”åˆ‡é™¤ (SHAPE)ã€‚"}]},
        {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [{"title": "Maintenance Therapy", "content": "ä¸€ç·šè½‰ç§»æ€§æ–¹æ¡ˆå¾ŒçºŒç”¨ IO ç¶­æŒ (KN826)ã€‚"}]},
        {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (Recurr Tx)", "css": "r-tx", "subs": [
            {"title": "Recurr / Metastatic", "content": "ä¸€ç·š Pembro+åŒ–ç™‚Â±Bev (KN826) æˆ– Atezoçµ„åˆ (BEATcc)ã€‚äºŒç·š ADC (innovaTV)ã€‚"}]}
    ]
}

# --- 2. ç¶œåˆå¯¦è­‰è³‡æ–™åº« (33+ ç ”ç©¶å…¨æ–¹ä½æ•´åˆ) ---
all_trials_db = [
    # --- ğŸ“š Published Milestones ---
    {"cancer": "Endometrial", "pos": "P-TX", "sub_pos": ["dMMR / MSI-H"], "name": "ğŸ“š RUBY", "pharma": "GSK", "drug": "Dostarlimab + CP", 
     "popover_summary": "dMMR æ—ç¾¤æ ¸å¿ƒç ”ç©¶ï¼šæ­»äº¡é¢¨éšªé™ 68% (HR 0.32)ï¼Œå¥ å®šä¸€ç·šå…ç–«åŠ åŒ–ç™‚æ¨™æº–ã€‚",
     "rationale": "PD-1 é˜»æ–·èˆ‡åŒ–ç™‚å…·å”åŒ ICD æ•ˆæ‡‰ï¼Œé‡å° MMRd æ—ç¾¤é”åˆ°æ¥µé«˜æŒä¹…æ‡‰ç­”ç‡ã€‚",
     "regimen": "Dosta 500mg Q3W + CP x6 é€±æœŸ -> ç¶­æŒ Dosta 1000mg Q6W æœ€é•· 3å¹´ã€‚",
     "inclusion": ["æ–°è¨ºæ–· Stage III-IV æˆ–é¦–æ¬¡å¾©ç™¼ ECã€‚", "åŒ…å« Carcinosarcoma çµ„ç¹”å‹æ…‹ã€‚"],
     "exclusion": ["å…ˆå‰æ¥å—éç³»çµ±æŠ—ç™Œæ²»ç™‚ã€‚", "æ´»å‹•æ€§è‡ªé«”å…ç–«ç–¾ç—…ã€‚"],
     "outcomes": "dMMR: HR 0.32 (PFS); mOS 44.6m (vs 28.2m, HR 0.69)."},

    {"cancer": "Endometrial", "pos": "P-TX", "sub_pos": ["dMMR / MSI-H", "pMMR / NSMP / MSS"], "name": "ğŸ“š NRG-GY018", "pharma": "MSD", "drug": "Pembrolizumab + CP", 
     "popover_summary": "ä¸é™ MMR åˆ†å‹ä¸€ç·šå…ç–«ï¼šdMMR PFS HR 0.30; pMMR HR 0.54ã€‚",
     "regimen": "Pembro 200mg Q3W + CP x6 -> ç¶­æŒ 400mg Q6W æœ€é•· 2å¹´ã€‚",
     "outcomes": "dMMR PFS HR 0.30; pMMR HR 0.54."},

    {"cancer": "Endometrial", "pos": "P-TX", "sub_pos": ["pMMR / NSMP / MSS"], "name": "ğŸ“š DUO-E", "pharma": "AZ", "drug": "Durvalumab + CP â†’ç¶­æŒ Â± Ola", 
     "popover_summary": "ä¸€ç·šç¶­æŒç­–ç•¥ï¼šä¸‰è—¥çµ„å°‡ pMMR PFS HR é™è‡³ 0.57ï¼Œæ¢ç´¢ç¶­æŒéšæ®µä¹‹å”åŒåƒ¹å€¼ã€‚",
     "results": "ä¸‰è—¥çµ„ PFS HR 0.57 (vs CP)."},

    {"cancer": "Endometrial", "pos": "P-TX", "sub_pos": ["dMMR / MSI-H"], "name": "ğŸ“š AtTEnd", "pharma": "Roche", "drug": "Atezolizumab + CP", 
     "popover_summary": "ä¸€ç·šæ™šæœŸ/å¾©ç™¼ï¼šdMMR PFS HR 0.36ï¼Œç¢ºèª PD-L1 ä½µç”¨åŒ–ç™‚åƒ¹å€¼ã€‚",
     "outcomes": "dMMR PFS HR 0.36; ITT OS HR 0.82."},

    {"cancer": "Endometrial", "pos": "R-TX", "sub_pos": ["Recurrent EC"], "name": "ğŸ“š KEYNOTE-775", "pharma": "MSD/Eisai", "drug": "Lenvatinib + Pembro", 
     "popover_summary": "MSS/pMMR äºŒç·šæ¨™æº–ï¼šOS 17.4m vs 12.0mï¼Œç¢ºç«‹å¾Œç·šæ¨™é¶å…ç–«é ˜å…ˆåœ°ä½ã€‚",
     "outcomes": "pMMR OS HR 0.68; mOS 17.4m (vs 12.0m)."},

    {"cancer": "Endometrial", "pos": "R-TX", "sub_pos": ["Recurrent EC"], "name": "ğŸ“š GARNET", "pharma": "GSK", "drug": "Dostarlimab å–®è—¥", 
     "popover_summary": "MSI-H å¾Œç·šå…ç–«å–®è—¥ï¼šORR 45.5%ï¼Œæä¾›æŒä¹…ç·©è§£æ•¸æ“šã€‚",
     "outcomes": "dMMR ORR 45.5%; DOR æœªé”åˆ°ã€‚"},

    # --- Cervical Published ---
    {"cancer": "Cervical", "pos": "P-TX", "sub_pos": ["Locally Advanced (CCRT)"], "name": "ğŸ“š KEYNOTE-A18", "pharma": "MSD", "drug": "Pembrolizumab + CCRT", 
     "popover_summary": "LACC åŒæ­¥å…ç–«æ¨™æº–ï¼š36å€‹æœˆ OS 82.6% (vs 74.8%)ï¼Œé¡¯è‘—æ”¹å–„æ ¹æ²»å­˜æ´»ã€‚",
     "outcomes": "OS HR 0.67; 36m OS 82.6%."},

    {"cancer": "Cervical", "pos": "P-TX", "sub_pos": ["Locally Advanced (CCRT)"], "name": "ğŸ“š INTERLACE", "pharma": "UCL", "drug": "Induction Carbo/Pacli x6", 
     "popover_summary": "èª˜å°åŒ–ç™‚åƒ¹å€¼ï¼šå…ˆ 6é€±èª˜å°åŒ–ç™‚å† CCRT é¡¯è‘—æå‡ 5å¹´ OS (HR 0.60)ã€‚",
     "outcomes": "5yr OS 80% (vs 72%)."},

    {"cancer": "Cervical", "pos": "P-TX", "sub_pos": ["Locally Advanced (CCRT)"], "name": "ğŸ“š CALLA", "pharma": "AZ", "drug": "Durvalumab + CCRT", 
     "popover_summary": "é™°æ€§è©¦é©—æé†’ï¼šDurva + CCRT æ•´é«”æœªé”æ¨™ (HR 0.84)ã€‚",
     "outcomes": "PFS HR 0.84 (P=NS)."},

    {"cancer": "Cervical", "pos": "R-TX", "sub_pos": ["Recurr / Metastatic"], "name": "ğŸ“š KEYNOTE-826", "pharma": "MSD", "drug": "Pembro + Chemo Â± Bev", 
     "popover_summary": "R/M ä¸€ç·šæ ¸å¿ƒæ–¹æ¡ˆï¼šå…¨äººç¾¤æ­»äº¡é¢¨éšªé™ 37%ï¼ŒCPSâ‰¥1 ç²ç›Šæ¥µé¡¯è‘—ã€‚",
     "outcomes": "OS HR 0.63; CPSâ‰¥1 HR 0.60."},

    {"cancer": "Cervical", "pos": "R-TX", "sub_pos": ["Recurr / Metastatic"], "name": "ğŸ“š BEATcc", "pharma": "Roche", "drug": "Atezo + Chemo + Bev", 
     "popover_summary": "ä¸€ç·šå¾©ç™¼/è½‰ç§»ï¼šPFS/OS çš†æ”¹å–„ï¼Œæä¾› Atezo ä½µç”¨æ–°é¸é …ã€‚",
     "outcomes": "PFS HR 0.62; OS HR 0.68."},

    {"cancer": "Cervical", "pos": "R-TX", "sub_pos": ["Recurr / Metastatic"], "name": "ğŸ“š EMPOWER-Cx 1", "pharma": "Regeneron", "drug": "Cemiplimab", 
     "popover_summary": "äºŒç·šå…ç–« OS è­‰æ“šï¼šOS 12.0m vs 8.5mï¼Œç²ç›Šä¸ä¾è³´ PD-L1 è¡¨ç¾ã€‚",
     "outcomes": "OS HR 0.69; mOS 12.0m."},

    {"cancer": "Cervical", "pos": "R-TX", "sub_pos": ["Recurr / Metastatic"], "name": "ğŸ“š innovaTV 301", "pharma": "Genmab", "drug": "Tisotumab Vedotin (ADC)", 
     "popover_summary": "å¾Œç·š ADC çªç ´ï¼šOS HR 0.70; ORR 17.8%ï¼ŒADC æ­£å¼é€²å…¥å¾Œç·šæ¨™æº–ã€‚",
     "outcomes": "OS HR 0.70; ORR 17.8%."},

    {"cancer": "Cervical", "pos": "P-TX", "sub_pos": ["Early Stage (Surgery)"], "name": "ğŸ“š SHAPE trial", "pharma": "CCTG", "drug": "Simple Hysterectomy", 
     "popover_summary": "æ‰‹è¡“é™éšå¯¦è­‰ï¼šä½é¢¨éšªæ‚£è€…å–®ç´”å…¨å­å®®åˆ‡é™¤å¾©ç™¼ç‡èˆ‡æ ¹æ²»è¡“ç›¸ç•¶ã€‚",
     "outcomes": "3yr Recurrence: 2.5% vs 2.2%."},

    # --- Ovarian ---
    {"cancer": "Ovarian", "pos": "P-MT", "sub_pos": ["BRCA mutation"], "name": "ğŸ“š SOLO-1", "pharma": "AZ", "drug": "Olaparib ç¶­æŒ", 
     "popover_summary": "BRCAm é‡Œç¨‹ç¢‘ï¼š7å¹´å­˜æ´»ç‡ 67%ï¼Œç¢ºç«‹ä¸€ç·š PARPi ç¶­æŒæ²»ç™’æ½›åŠ›ã€‚",
     "outcomes": "7yr survival 67% (HR 0.33)."},

    {"cancer": "Ovarian", "pos": "P-MT", "sub_pos": ["HRD positive / BRCA wt"], "name": "ğŸ“š PRIMA", "pharma": "GSK", "drug": "Niraparib ç¶­æŒ", 
     "popover_summary": "å…¨äººç¾¤ç¶­æŒï¼šHRD+ PFS HR 0.43ï¼Œæ”¯æŒä¸é™ BRCA ä¹‹ç¶­æŒç­–ç•¥ã€‚",
     "outcomes": "HRD+ PFS HR 0.43; ITT HR 0.62."},

    {"cancer": "Ovarian", "pos": "P-MT", "sub_pos": ["HRD positive / BRCA wt"], "name": "ğŸ“š PAOLA-1", "pharma": "AZ", "drug": "Olaparib + Bevacizumab", 
     "popover_summary": "HRD+ é»ƒé‡‘çµ„åˆï¼š5å¹´ OS ç‡ 75.2%ï¼Œç¢ºç«‹çµ„åˆç¶­æŒå‹æ–¼ Bev å–®è—¥ã€‚",
     "outcomes": "HRD+ OS HR 0.62; 5yr OS 75.2%."},

    {"cancer": "Ovarian", "pos": "P-MT", "sub_pos": ["BRCA mutation", "HRD positive / BRCA wt"], "name": "ğŸ“š ATHENAâ€“MONO", "pharma": "Clovis", "drug": "Rucaparib ç¶­æŒ", 
     "popover_summary": "ä¸€ç·šå…¨äººç¾¤ç¶­æŒï¼šITT PFS HR 0.52 (28.7m vs 11.3m)ã€‚",
     "outcomes": "ITT PFS HR 0.52."},

    {"cancer": "Ovarian", "pos": "R-MT", "sub_pos": ["Platinum Sensitive Maint"], "name": "ğŸ“š NOVA", "pharma": "GSK", "drug": "Niraparib ç¶­æŒ", 
     "popover_summary": "å¾©ç™¼ç¶­æŒåŸºçŸ³ï¼šgBRCA HR 0.27; é gBRCA HR 0.45ã€‚",
     "outcomes": "gBRCA HR 0.27; Non-gBRCA HR 0.45."},

    {"cancer": "Ovarian", "pos": "R-MT", "sub_pos": ["Platinum Sensitive Maint"], "name": "ğŸ“š ARIEL3", "pharma": "Clovis", "drug": "Rucaparib ç¶­æŒ", 
     "popover_summary": "æ‰€æœ‰åˆ†å±¤ç²ç›Šï¼šBRCAm HR 0.23; HRD+ HR 0.32ã€‚",
     "outcomes": "BRCAm HR 0.23; HRD+ HR 0.32."},

    {"cancer": "Ovarian", "pos": "R-MT", "sub_pos": ["Platinum Sensitive Maint"], "name": "ğŸ“š SOLO2", "pharma": "AZ", "drug": "Olaparib ç¶­æŒ", 
     "popover_summary": "BRCAm å¾©ç™¼ OSï¼šmOS 51.7m vs 38.8m (HR 0.74)ã€‚",
     "outcomes": "mOS 51.7m vs 38.8m."},

    {"cancer": "Ovarian", "pos": "P-MT", "sub_pos": ["HRD positive / BRCA wt"], "name": "ğŸ“š DUO-O", "pharma": "AZ", "drug": "Durva+Ola+Bev ç¶­æŒ", 
     "popover_summary": "å…ç–«çµ„åˆå„ªå‹¢ï¼šHRD+ PFS HR 0.49ï¼Œé¡¯ç¤º IO çµ„åˆç­–ç•¥æ½›åŠ›ã€‚",
     "outcomes": "HRD+ PFS HR 0.49."},

    {"cancer": "Ovarian", "pos": "R-TX", "sub_pos": ["PROC (Resistant Recur)"], "name": "ğŸ“š MIRASOL", "pharma": "ImmunoGen", "drug": "Mirvetuximab", 
     "popover_summary": "PROC OS çªç ´ï¼šOS HR 0.67; ORR 42.3%ï¼Œæ”¹è®ŠæŠ—è—¥å‹æ²»ç™‚æ¨™æº–ã€‚",
     "outcomes": "OS HR 0.67; ORR 42.3%."},

    {"cancer": "Ovarian", "pos": "P-TX", "sub_pos": ["HGSC / Endometrioid"], "name": "ğŸ“š HIPEC (van Driel)", "pharma": "NEJM 2018", "drug": "Surgery + HIPEC", 
     "popover_summary": "IDS æ‰‹è¡“åŠ æº«ï¼šmOS å»¶é•· 12 å€‹æœˆ (HR 0.67)ï¼Œå¼·åŒ–å¾®å°ç—…ç¶æ®ºå‚·ã€‚",
     "outcomes": "mOS 45.7m vs 33.9m."},

    {"cancer": "Ovarian", "pos": "R-TX", "sub_pos": ["PSOC (Sensitive Recur)"], "name": "ğŸ“š DESKTOP III", "pharma": "NEJM 2021", "drug": "Secondary Surgery", 
     "popover_summary": "äºŒæ¬¡æ¸›ç©åƒ¹å€¼ï¼šåš´é¸æ‚£è€… (AGO+) mOS 53.7m vs 46.0mã€‚",
     "outcomes": "mOS 53.7m vs 46.0m (HR 0.75)."},

    {"cancer": "Ovarian", "pos": "P-TX", "sub_pos": ["HGSC / Endometrioid"], "name": "ğŸ“š LION", "pharma": "NEJM 2019", "drug": "No Lymphadenectomy", 
     "popover_summary": "æ‰‹è¡“æ¸›è¼•è² æ“”ï¼šè‡¨åºŠ LN é™°æ€§å…æ¸…æƒï¼ŒOS ç„¡å·®ç•° (HR 1.06)ã€‚",
     "outcomes": "OS HR 1.06."},

    # --- ğŸ“ Ongoing Trials (æ•‘æ´ 8 æ ¸å¿ƒ) ---
    {"cancer": "Ovarian", "name": "ğŸ“ FRAmework-01", "pharma": "Eli Lilly", "drug": "LY4170156 + Bevacizumab", "pos": "R-TX", "sub_pos": ["PROC (Resistant Recur)"], "type": "Ongoing",
     "popover_summary": "FRÎ± ADC ä½µç”¨è¡€ç®¡æ–°ç”ŸæŠ‘åˆ¶åŠ‘ï¼šæå‡æ»²é€æ®ºå‚·ã€‚",
     "rationale": "æ¨™é¶ FRÎ± ADC è¯ç”¨ anti-VEGF ç”¢ç”Ÿè¡€ç®¡é‡å¡‘å”åŒä½œç”¨ (Synergy)ï¼Œæå‡è—¥ç‰©æ»²é€æ·±åº¦ã€‚",
     "regimen": "LY4170156 3mg/kg IV + Bevacizumab 15mg/kg IV Q3Wã€‚",
     "inclusion": ["FRÎ± è¡¨é”é™½æ€§ã€‚", "æœ€å¾Œé‰‘é¡å¾Œ 90â€“180 å¤©å…§æƒ¡åŒ– (PROC)ã€‚"]},

    {"cancer": "Ovarian", "name": "ğŸ“ REJOICE-Ovarian01", "pharma": "Daiichi Sankyo", "drug": "R-DXd", "pos": "R-TX", "sub_pos": ["PROC (Resistant Recur)"], "type": "Ongoing",
     "popover_summary": "æ¨™é¶ CDH6 ADCï¼šå°ˆæ”»é«˜åº¦ç•°è³ªæ€§ä¹‹ PROC ç’°å¢ƒã€‚",
     "rationale": "æ¨™é¶ Cadherin-6 (CDH6) ADCï¼Œå…·å¼·åŠ›æ—è§€è€…æ•ˆæ‡‰å…‹æœå‰ç·šåŒ–ç™‚è€è—¥æ€§ã€‚",
     "regimen": "R-DXd 5.6mg/kg IV Q3Wã€‚",
     "inclusion": ["HG Serous æˆ– Endometrioid PROCã€‚", "æä¾›åˆ‡ç‰‡é€²è¡Œ CDH6 åˆ†å±¤ã€‚"]},

    {"cancer": "Ovarian", "name": "ğŸ“ TroFuse-021", "pharma": "MSD", "drug": "Sac-TMT (MK-2870) + Bev", "pos": "P-MT", "sub_pos": ["HRD negative"], "type": "Ongoing",
     "popover_summary": "æ¨™é¶ Trop-2 ADC çµ„åˆï¼šæ—¨åœ¨å„ªåŒ–ç¶­æŒéšæ®µç²ç›Šã€‚",
     "rationale": "æ¨™é¶ Trop-2 ADC å”åŒ Beva å¾®ç’°å¢ƒèª¿ç¯€èˆ‡ ADC èª˜å°ä¹‹ ICD æ•ˆæ‡‰æŒ‘æˆ°ä¸€ç·šç¶­æŒæ¨™æº–ã€‚"},

    {"cancer": "Endometrial", "name": "ğŸ“ MK2870-033", "pharma": "MSD", "drug": "Sac-TMT + Pembrolizumab", "pos": "P-MT", "sub_pos": ["Maintenance"], "type": "Ongoing",
     "popover_summary": "Trop-2 ADC å”åŒ PD-1ï¼šæå‡ pMMR/NSMP æ‡‰ç­”æ·±åº¦ã€‚",
     "regimen": "Pembro 400mg Q6W + Sac-TMT 5mg/kg Q6Wã€‚"},

    {"cancer": "Endometrial", "name": "ğŸ“ GU-US-682-6769", "pharma": "Gilead", "drug": "SG (Trodelvy)", "pos": "R-TX", "sub_pos": ["Recurrent EC"], "type": "Ongoing",
     "popover_summary": "æ¨™é¶ Trop-2 ADC åˆ©ç”¨ SN-38 è¼‰è·å°æŠ—é‰‘é¡å…ç–«å¤±æ•—ã€‚",
     "regimen": "SG 10mg/kg (D1, D8 Q21D)ã€‚"},

    {"cancer": "Ovarian", "name": "ğŸ“ DS8201-772 (Enhertu)", "pharma": "AstraZeneca", "drug": "T-DXd", "pos": "R-MT", "sub_pos": ["Platinum Sensitive Maint"], "type": "Ongoing",
     "popover_summary": "HER2 ADC æ•‘æ´å¾Œç¶­æŒï¼šæ¸…é™¤ HER2 è¡¨ç¾æ®˜ç•™ç—…ç¶ã€‚",
     "inclusion": ["HER2 IHC 1+/2+/3+ ç¢ºèªã€‚", "PSOC æ•‘æ´åŒ–ç™‚é”ç©©å®š (Non-PD)ã€‚"]},

    {"cancer": "Ovarian", "name": "ğŸ“ DOVE", "pharma": "GSK", "drug": "Dostarlimab + Bevacizumab", "pos": "R-TX", "sub_pos": ["PROC (Resistant Recur)"], "type": "Ongoing",
     "popover_summary": "é‡å° OCCC é€æ˜ç´°èƒç™Œåˆ©ç”¨é›™é‡é˜»æ–·æ”¹å–„å¾®ç’°å¢ƒã€‚",
     "inclusion": ["çµ„ç¹”å­¸ OCCC > 50%ã€‚", "é‰‘é¡æŠ—è—¥æ€§ (PFI < 12m)ã€‚"]},
]

# --- 3. å‹•æ…‹æ¨¡å‹èˆ‡ AI åª’åˆ ---
def get_gemini_model():
    try:
        available_models = [m.name for m in genai.list_models() if 'generateContent' in m.supported_generation_methods]
        target_model = next((m for m in available_models if 'gemini-1.5-flash' in m), None)
        if not target_model: target_model = next((m for m in available_models if 'gemini-pro' in m), None)
        if target_model: return genai.GenerativeModel(target_model)
    except: return None

# --- 4. å´é‚Šæ¬„ï¼šæ‚£è€…åˆ†æèˆ‡çœ‹æ¿åŒæ­¥ ---
with st.sidebar:
    st.markdown("<h3 style='color: #6A1B9A;'>ğŸ¤– AI å¯¦è­‰åª’åˆåŠ©ç†</h3>", unsafe_allow_html=True)
    api_key = st.text_input("Gemini API Key", type="password")
    with st.expander("âœ¨ æ‚£è€…ç—…æ­·æ·±åº¦åª’åˆ", expanded=True):
        p_notes = st.text_area("è¼¸å…¥æ‘˜è¦ (å«ç´°èƒå‹æ…‹/æ¨™è¨˜)", placeholder="ä¾‹å¦‚ï¼šEC IIIæœŸ, dMMR, p53 mutation...", height=220)
        if st.button("ğŸš€ é–‹å§‹åª’åˆ"):
            if api_key and p_notes:
                try:
                    genai.configure(api_key=api_key)
                    model = get_gemini_model()
                    prompt = f"åˆ†æç—…æ­·ï¼š{p_notes}ã€‚è«‹åƒè€ƒå¯¦è­‰åº«ï¼š{all_trials_db}ã€‚å»ºè­°é©åˆè·¯å¾‘èˆ‡ç†ç”±ã€‚"
                    st.write(model.generate_content(prompt).text)
                except Exception as e: st.error(f"AI ç•°å¸¸: {e}")

# --- 5. ä¸»é é¢ï¼šå°èˆªåœ°åœ– ---
st.markdown("<div class='main-title'>å©¦ç™Œè‡¨åºŠå°èˆªå„€è¡¨æ¿ (2026 æ——è‰¦å¯¦è­‰æ•´åˆç‰ˆ)</div>", unsafe_allow_html=True)
cancer_type = st.radio("ç¬¬ä¸€æ­¥ï¼šé¸æ“‡ç™Œç—‡é¡å‹", ["Endometrial", "Ovarian", "Cervical"], horizontal=True)

cols = st.columns(len(guidelines_nested[cancer_type]))
stages_data = guidelines_nested[cancer_type]

for i, stage in enumerate(stages_data):
    with cols[i]:
        st.markdown(f"""<div class='big-stage-card card-{stage['css']}'><div class='big-stage-header header-{stage['css']}'>{stage['header']}</div>""", unsafe_allow_html=True)
        for sub in stage['subs']:
            st.markdown(f"""<div class='sub-block'><div class='sub-block-title'>ğŸ“˜ {sub['title']}</div><div class='sub-block-content'>{sub['content']}</div>""", unsafe_allow_html=True)
            rel_trials = [t for t in all_trials_db if t["cancer"] == cancer_type and t["pos"] == stage["id"] and any(s in sub["title"] for s in t["sub_pos"])]
            for t in rel_trials:
                label = f"{t.get('pharma', 'N/A')} | {t['name']} | {t['drug']}"
                with st.popover(label, use_container_width=True):
                    st.success(f"**æ ¸å¿ƒæ‘˜è¦:** {t.get('popover_summary', 'æ‹›å‹Ÿä¸­')}")
                    unique_key = f"sync_{t['name']}_{cancer_type}_{stage['id']}_{sub['title'].replace(' ', '')}"
                    if st.button("ğŸ“Š åŒæ­¥çœ‹æ¿ç´°ç¯€", key=unique_key):
                        st.session_state.selected_trial = t['name']
                        st.rerun() # å¼·åˆ¶åŒæ­¥
            st.markdown("</div>", unsafe_allow_html=True)
        st.markdown("</div>", unsafe_allow_html=True)

# --- 6. æ·±åº¦æ•¸æ“šçœ‹æ¿ (Bottom Selector) ---
st.divider()
st.subheader("ğŸ“‹ è‡¨åºŠç ”ç©¶æ¥µé‡åŒ–æ•¸æ“šåº« (Published Milestones & Ongoing Trials)")
filtered_list = [t for t in all_trials_db if t["cancer"] == cancer_type]
try: curr_idx = [t["name"] for t in filtered_list].index(st.session_state.selected_trial)
except: curr_idx = 0

selected_name = st.selectbox("ğŸ¯ å¿«é€Ÿé¸æ“‡ç ”ç©¶è¨ˆç•«ä»¥æŸ¥é–±è©³ç´°å…§å®¹ï¼š", [t["name"] for t in filtered_list], index=curr_idx, key="trial_selector")
st.session_state.selected_trial = selected_name
t = next(it for it in all_trials_db if it["name"] == selected_name)

st.markdown(f"<div class='detail-section'>", unsafe_allow_html=True)
st.markdown(f"<h2 style='color:#004D40; border-bottom:3px solid #E0E0E0; padding-bottom:10px; font-weight:900;'>ğŸ“‹ {t['name']} æ·±åº¦æ•¸æ“šåˆ†æå ±å‘Š</h2>", unsafe_allow_html=True)

r1, r2 = st.columns([1.3, 1])
with r1:
    st.markdown("<div style='background:#E3F2FD; border-left:10px solid #1976D2; padding:15px; border-radius:10px;'><b>ğŸ’‰ Rationale & Regimen (æ©Ÿè½‰èˆ‡çµ¦è—¥)</b></div>", unsafe_allow_html=True)
    st.write(f"**æ ¸å¿ƒä»‹å…¥:** {t['drug']}")
    st.write(f"**è©³ç´°çµ¦è—¥æ–¹æ¡ˆ:** {t.get('regimen', 'è©³è¦‹æ‹›å‹Ÿç´°å‰‡ã€‚')}")
    st.success(f"**ç§‘å­¸ç†æ“š (Scientific Rationale):** {t.get('rationale', 'æ—¨åœ¨æŒ‘æˆ°ç¾æœ‰ SoC ç“¶é ¸ï¼Œæå‡ç”Ÿå­˜ç²ç›Šã€‚')}")
    

with r2:
    st.markdown("<div style='background:#FFF8E1; border-left:8px solid #FBC02D; padding:15px; border-radius:10px;'><b>ğŸ“ˆ Key Outcomes (æœ€æ–°ç”Ÿå­˜èˆ‡ç·©è§£æŒ‡æ¨™)</b></div>", unsafe_allow_html=True)
    st.markdown(f"""
        <div style='text-align:center; background:white; padding:15px; border:2px solid #FFE082; border-radius:12px;'>
            <div style='font-size: 14px; color: #795548; font-weight:700; margin-bottom:5px;'>Survival Metrics (PFS/OS/HR/ORR)</div>
            <div class='hr-big-val'>{t.get('outcomes', 'Ongoing')}</div>
        </div>
    """, unsafe_allow_html=True)
    

st.divider()
r3, r4 = st.columns(2)
with r3:
    st.markdown("<div style='background:#E8F5E9; border-left:8px solid #2E7D32; padding:15px; border-radius:10px;'><b>âœ… Inclusion Criteria (é—œéµç´å…¥æ¨™æº–)</b></div>", unsafe_allow_html=True)
    for inc in t.get('inclusion', ['è©³è¦‹å…¨æ–‡ã€‚']): st.write(f"â€¢ **{inc}**")
with r4:
    st.markdown("<div style='background:#FFEBEE; border-left:8px solid #C62828; padding:15px; border-radius:10px;'><b>âŒ Exclusion Criteria (é—œéµæ’é™¤æ¨™æº–)</b></div>", unsafe_allow_html=True)
    for exc in t.get('exclusion', ['è©³è¦‹å…¨æ–‡ã€‚']): st.write(f"â€¢ **{exc}**")
st.markdown("</div>", unsafe_allow_html=True)
